Pamepsin ranked among the top searched stocks on 3 days within the past month.

As of 12:31 PM on the 8th, Pamepsin is trading at 25,050 KRW, up 4.81% from the previous day. This is a 55.59% decrease compared to June 19.

Over the past 5 days, individual investors have net purchased 115,602 shares, while foreigners and institutions have net sold 75,406 shares and 25,562 shares, respectively.

On July 7, Pamepsin became a market issue with the headline "Anticancer drug clinical trial progressing smoothly, 15% rise."

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing